Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
UBS ETF - Bloomberg Barclays US Liquid Corporates UCITS ETFCBUS-0.022.870.10-1.40-149.74%-53.00%53.76$3.09$44.432,427$2.53

Detail of UBS ETF - Bloomberg Barclays US Liquid Corporates UCITS ETF

 
CEO
Mr. Rory Balfour Riggs M.B.A.
Employees
183
Industry
Biotechnology
Sector
Healthcare
Market cap
$12M

Company details

Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.

Revenue
Revenue (Rev)
$4.15M
UBS ETF - Bloomberg Barclays US Liquid Corporates UCITS ETF
CBUS • XNGS • US
$2.53
-15.34 (-85.89%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$113.22
Margin profit
0.00%
52 week low
$2.20
52 week high
$22.82
50-day simple moving average
$2.50
200-day simple moving average
$3.09
Percent held by insiders
25.26%
Percent held by institutions
28.97%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
CBUS -86.54%
eps change
CBUS 0.00%